Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Ra Capital Management, L.P. reported a 12.60% stake in Werewolf Therapeutics, Inc. (Schedule 13D/A)
Event May 12, 2026 · Filed May 14, 2026
Ra Capital Management, L.P. reported a 12.60% stake in Werewolf Therapeutics, Inc., 6,116,140 shares, with active intent on May 12, 2026. Filed May 14, 2026 (Schedule 13D/A).
- Stake
- 12.60%
- Shares
- 6,116,140
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 12.60% | 6,116,140 |
| Peter Kolchinsky | 12.60% | 6,116,140 |
| Rajeev Shah | 12.60% | 6,116,140 |
| RA Capital Healthcare Fund, L.P. | 11.70% | 5,709,858 |
Source
Related
- Werewolf Therapeutics, Inc.
- Ra Capital Management, L.P.
- Werewolf Therapeutics, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 22, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 15, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Nov 6, 2025
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 16, 2026